MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 2, 2007; DOI: 10.1124/mol.107.040873


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.040873v1
73/1/119    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, L.
Right arrow Articles by Rojanasakul, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, L.
Right arrow Articles by Rojanasakul, Y.


Received for publication August 15, 2007.
Revised October 2, 2007.
Accepted for publication October 2, 2007.

Peroxide is a Key Mediator of Bcl-2 Downregulation and Apoptosis Induction by Cisplatin in Human Lung Cancer Cells

Liying Wang 1, Pithi Chanvorachote 2, David Toledo 3, Christian Stehlik 4, Robert R Mercer 1, Vincent Castranova 1, Yon Rojanasakul 3*

1 National Institute for Occupational Safety and Health 2 Chulalongkorn University 3 West Virginia University 4 Northwestern University

* Address correspondence to: E-mail: yrojanasakul{at}hsc.wvu.edu

Abstract

Susceptibility to apoptosis is an essential prerequisite for successful eradication of tumor cells by chemotherapy. Consequently, resistance to apoptosis has been established as one of the mechanisms responsible for the failure of therapeutic approaches in many types of cancers. In the present study, we investigated the susceptibility of human lung cancer H460 cells to apoptotic cell death induced by cisplatin and determined its regulatory mechanisms. Treatment of the cells with cisplatin induced rapid generation of multiple oxidative species and a concomitant increase in apoptotic cell death. Apoptosis induced by cisplatin was mediated through the mitochondrial death pathway which requires caspase-9 activation and is regulated by Bcl-2. Cisplatin induced downregulation of Bcl-2 through a process that involves dephosphorylation and ubiquitination of the protein which facilitates its degradation by proteasome. This downregulation was inhibited by antioxidant enzymes catalase and glutathione peroxidase (H2O2 scavenger), but not by superoxide dismutase (O2.- scavenger) or deferoxamine (OH. inhibitor). Electron spin resonance and flow cytometric analyses showed the formation of H2O2 along with O2.- and OH. radicals after cisplatin treatment. H2O2 was generated in part by dismutation of O2.- and served as a precursor for OH.. Together, our results indicate an essential role of H2O2 in the regulation of Bcl-2 and apoptotic cell death induced by cisplatin. Since aberrant expression of Bcl-2 has been associated with death resistance of cancer cells to chemotherapy, the results of this study could be used to aid the design of more effective strategies for cancer treatment.


Key words: Regulation of gene expression, Oxidative stress/antioxidants, Mechanisms of cell killing/apoptosis





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics